| Literature DB >> 26012510 |
Hongwei Lv1,2, Lisha Li3, Meiyu Sun4, Yin Zhang5,6, Li Chen7,8, Yue Rong9,10, Yulin Li11.
Abstract
Stem cell behaviors are regulated by multiple microenvironmental cues. As an external signal, mechanical stiffness of the extracellular matrix is capable of governing stem cell fate determination, but how this biophysical cue is translated into intracellular signaling remains elusive. Here, we elucidate mechanisms by which stem cells respond to microenvironmental stiffness through the dynamics of the cytoskeletal network, leading to changes in gene expression via biophysical transduction signaling pathways in two-dimensional culture. Furthermore, a putative rapid shift from original mechanosensing to de novo cell-derived matrix sensing in more physiologically relevant three-dimensional culture is pointed out. A comprehensive understanding of stem cell responses to this stimulus is essential for designing biomaterials that mimic the physiological environment and advancing stem cell-based clinical applications for tissue engineering.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26012510 PMCID: PMC4445995 DOI: 10.1186/s13287-015-0083-4
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Figure 1Mechanism of mechanotransduction of stem cells activated by matrix stiffness. The initial tension caused by stress fiber contraction is balanced by the microtubules resisting the resulting compression forces and the traction stress exerted on the extracellular matrix (ECM) across the focal adhesions, which directly cause the resultant force determined by matrix stiffness, contributing to microtubule compression. Then, the cell reads out the resultant forces from traction stress through the activation of integrin-mediated signal transduction pathways, which mediate actin filament polymerization and therefore change stress fiber contractility. Also, the initial tension from stress fiber contraction and the opposing compressive forces exerted by microtubules might also transmit into the nucleus and be resisted by lamin-A, which in turn promotes cell contractility by activating the transcriptional pathway that regulates actin filament bundling. Through cytoskeleton-based feedback loops, a cell changes its maximal mechanosensitivity close to the microtubule compression determined by matrix stiffness. Some transcriptional pathway modulates lamin-A expression, and feedback by lamin-A indirectly regulates transcriptional pathways, which crosstalk with integrin-mediated signaling and ultimately direct stem cell differentiation.
Effects of pharmacological cytoskeletal inhibitors on stem cell differentiation induced by matrix stiffness
|
|
|
|
|
|
|---|---|---|---|---|
| Blebbistatin | Myosin ATPase | Inhibits actomyosin contractility by blocking non-muscle myosin II ATPase activity | MSCs | Two-dimensional: blocks neurogenesis at 0.1 to 1 kPa, myogenesis at 8 to 17 kPa, osteogenesis at 25 to 40 kPa [ |
| Mammary progenitor cells | Two-dimensional: abrogates myoepithelial cell differentiation at 4 kPa [ | |||
| MSCs | Three-dimensional: no obvious effect on hypertrophic differentiation at approximately 53.6 kPa [ | |||
| ML-7 | Myosin light chain kinase | Inhibits actomyosin contractility by blocking myosin light chain phosphorylation | MSCs | Two-dimensional: blocks neurogenesis at 0.1 to 1 kPa, myogenesis at 8 to 17 kPa, osteogenesis at 25 to 40 kPa [ |
| MSCs | Three-dimensional: no obvious effect on osteogenesis at 0.2 to 59 kPa [ | |||
| Y27632 | ROCK | Inhibits actomyosin contractility by blocking the RhoA-ROCK pathway | Mammary progenitor cells | Two-dimensional: abrogates myoepithelial cell differentiation at 4 kPa [ |
| MSCs | Three-dimensional: no obvious effect on hypertrophic differentiation at ~53.6 kPa [ | |||
| Calyculin A | Myosin light chain phosphatase | Increases actomyosin contractility by inhibiting the myosin light chain phosphatase | Mammary progenitor cells | Two-dimensional: increases luminal epithelial cell differentiation at 0.1 kPa [ |
| Cytochalasin-D | Actin filament | Inhibits actin polymerization | ASCs | Two-dimensional: reduces the cellular area and aspect ratio of cells at 20 and 40 kPa and increases adipogenesis at 2 to 40 kPa, especially at 2 kPa [ |
| Latrunculin A | Monomeric G-actin | Inhibits actin polymerization | MSCs | Three-dimensional: increases osteogenesis at 0.2 to 59 kPa [ |
| Colchicine | Tubulin | Inhibits microtubule formation | MSCs | Three-dimensional: no obvious effect on osteogenesis at 0.2 to 59 kPa [ |
ASC, adipose-derived stem cell; MSC, mesenchymal stem cell; ROCK, Rho associated kinase.
Figure 2Stem cell response to matrix stiffness by integin, cytoskeleton and signal transduction crosstalk. (A) Integrin binding and cytoskeletal organization of stem cells seeded on substrates with varying stiffness. Left: on soft matrix stem cells present small spreading area, poorly defined actin cytoskeleton, low levels of lamin-A and detachment of focal adhesion complexes, associated with the uptake of integrins. Middle: on topographical substrates with medium stiffness, cells develop enlongated focal adhesions, intermediate levels of lamin-A, and well-aligned stress fibers with a spindle-shaped morphology. Right: stem cells cultured on rigid matrices display a large spreading size, prominent stress fibers and enhanced focal adhesion assembly, as well as high levels of lamin-A. BMP, bone morphogenetic protein; BMPR, bone morphogenetic protein receptor; RTK, receptor tyrosine kinase. (B) Crosstalk between signal transduction pathways induced by matrix stiffness to modulate stem cell lineage specification. Left: blocking of BMP/Smad signaling by enhanced uptake of β1 integrin through caveolae/raft-dependent endocytosis on soft matrix drives mesenchymal stem cell (MSC) neurogenic differentiation; lamin-A inhibits adipogenic differentiation by suppressing the , sterol regulatory element-binding transcription factor 1 (SREBP1) transcriptional pathway; blocking of integrin-mediated extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling, which may activate AP-1 by stimulation of Jun N-terminal kinase (JNK), leads to keratinocyte differentiation of epidermal stem cells. Middle: on topographical substrates with medium stiffness, MSCs employ β3 integrin-RhoA-Rho associated kinase (ROCK)-myosin light chain kinase (MLCK) pathways to promote actin filament bundling and stress fiber contraction to create appropriate cytoskeletal tension, which further influences myogenic gene expression; medium stiffness acts through β1 integrin, causing a reduction of p190RhoGAP, which results in nuclear localization of GATA2 and TFII-1 in a RhoA-independent manner, ultimately leading to endothelial differentiation of cardiac stem cells; nuclear localization of GATA2 inhibits Yes-associated protein 1 (YAP1) signaling that drives osteogenesis on stiff matrices. Right: on stiff matrix the α2-integrin-ROCK-FAK-ERK1/2 axis is shown to increase RUNX2 activity, leading to osteoblast differentiation of MSCs; Ras pathway regulates phosphorylation levels of Smad1/5/8, ERK1/2 and AKT during osteogenic differentiation; the retinoic acid (RA) pathway enhances lamin-A transcription, but feedback by lamin-A indirectly modulates nuclear localization of RA receptor gamma (RARG), which can be inhibited by RA and promotes RUNX2 activity on stiff substrates; lamin-A also co-regulates SRF and YAP1 to drive osteogenesis; SRF signaling in turn affects stress fiber contractility; increased intracellular Ca2+ ion concentration on rigid matrix may contribute to cytoskeleton tension through the activation of MLCK. Broken lines, unknown or putative signaling; solid lines, as in published. Arrows indicate activation, blocked lines inhibition.
Figure 3Discrepancy between two-dimensional and three-dimensional microenvironments. (A) Cells on a rigid two-dimensional (2D) surface coated with a continuous layer of matrix develop focal adhesions and stress fibers at the basal surface. Cell-matrix interactions are restricted to the planar direction and gradients of secreted factors are absent. (B) Inside a three-dimensional (3D) environment, cells display poorly defined stress fibers due to the softness of biomaterials. Cell adhesions are distributed both in the planar and perpendicular directions with discrete matrix fibrils, and secreted factors can be highly concentrated.
Effects of matrix stiffness on stem cells in two dimensions versus three dimensions
|
|
|
| |
|---|---|---|---|
| Two-dimensional | ESCs | Col I-coated PDMS: 41 to 260 kPa, lower cell perimeter and less spreading; 2,700 kPa, higher cell perimeter, increased spreading and more stress fibers [ | HyA gel: 1.2 kPa, pancreatic beta cell [ |
| Col I-coated PDMS: 2,700 kPa, mesendoderm cell and osteoblast [ | |||
| MSCs | FN-coated PAAm gel: 1 to 2 kPa, rounded and unspread; ≥5 kPa, well spread and amassed a large number of stress fibers [ | Col I gel and Col I-coated gel, 1 kPa, adipocyte and chondrocyte; 15 kPa, smooth muscle cell [ | |
| Col I gel and Col I-coated PAAm gel: 1 kPa, less spreading and fewer stress fibers; 15 kPa, more spreading and extensive stress fibers [ | Col I-coated PAAm gel: 0.1 to 1 kPa, neuron; 8 to 17 kPa, myoblast; 25 to 40 kPa, osteoblast [ | ||
| Col I-coated PAAm gel: 0.1 to 1 kPa, branched and filopodia-rich; 8 to 17 kPa, spindle-shaped; 25 to 40 kPa, polygonal [ | Sulfonate-coated PAAm:1 kPa, chondrocyte [ | ||
| Sulfonate-coated PAAm; 1 kPa, round shapes with less stress fibers but more cortical actins; 150 kPa, spread out with strong expression of stress fibers [ | |||
| ASCs | Adipose matrix-coated PAAm gel: 2 kPa, compact, rounded and smaller aspect ratio; 20 to ~40 kPa, more spreading and larger aspect ratio [ | Adipose matrix-coated PAAm gel: 2 kPa, adipocyte [ | |
| Cardiac stem cells | FN-coated PAAm gel: 12 to 16 kPa, more rounded and forming organized cellular networks with rounded gaps; FN-coated glass: fibroblast-like [ | FN-coated PAAm gel: 12 to 16 kPa, endothelial cell [ | |
| Mammary progenitor cells | Col I-coated PAAm gel: 0.1 kPa, cobblestone; 4 kPa, more elongated [ | Col I-coated PAAm gel: 0.1 kPa, luminal epithelial cell; 4 kPa, myoepithelial cell [ | |
| Three-dimensional | ESCs | Col I gel and matrigel: 0.02 to 0.3 kPa, less neurite outgrowth; 0.5 to 1 kPa, branching and more neurite outgrowth [ | PLLA, PLGA, PCL coated matrigel: 50 to 100 kPa, ectoderm cell; 100 to 1,000 kPa, endoderm cell; 1,500 to 6,000 kPa, mesoderm cell [ |
| Col I gel and matrigel: 0.02 to 0.3 kPa, glial cell; 0.5 to 1 kPa, neuron [ | |||
| MSCs | Col I-HyA gel: 1 kPa, spherical and formed colonies; 10 kPa, flattened [ | PEG-silica thixotropic gel: 7 Pa (τy)a, neuron; 25 Pa (τy) , myoblast; 75 Pa (τy), osteoblast [ | |
| PEG gel: 0.2 to 59 kPa, spherical, lack of well-defined actin filaments and microtubules [ | HyA hydrogel: 3.5 kPa, chondrocyte; 53.6 kPa, hypertrophy [ | ||
| Gtn-HPA gel: 0.6 to 2.5 kPa, less spreading, less organized cytoskeletons; 8 to 12 kPa, greater spreading, more organized cytoskeletons and more stable focal adhesions [ | Col I-HyA gel: 1 kPa, neuron; 10 kPa, glial cell [ | ||
| PEG gel: 0.2 to 59 kPa, osteoblast [ | |||
| Gtn-HPA gel: 0.6 to 2.5 kPa, neuron; 8 to 12 kPa, myoblast [ | |||
| Alginate gel containing RGD: 5, 10, 22, 45, 110 kPa, grossly spherical and morphology are not strongly correlated to matrix stiffness [ | Col I-coated PEG nanofiber: 2 to 5 kPa, endothelial cell; 8 to 15 kPa, smooth muscle cell [ | ||
| Col I-coated PEG nanofiber: 2 to 5 kPa, less polarized; 8 to 15 kPa, striated, elongated and greater spreading [ | PCL nanofiber: 7,100 kPa, chondrocyte; PES-PCL nanofiber: 30,600 kPa, osteoblast [ | ||
| PCL nanofiber: 7,100 kPa, rounded; PES-PCL nanofiber: 30,600 kPa, spread and higher stress fiber density [ | |||
| Myoblasts | TG-Gtn gel: 2 kPa, elongated and branched, mesh-like or extended actin filaments; 14 to 32 kPa, dot-like actin microfilaments with filopodia [ | TG-Gtn gel: 14 to 32 kPa, osteoblast [ |
aτy (liquefaction stress): the minimum shear stress required to liquefy the gel is used to measure the substrate stiffness. ASC, adipose-derived stem cell; Col I, collagen I; ESC, embryonic stem cell; FN, fibronectin; Gtn-HPA, gelatin-hydroxyphenylpropionic acid; HyA, hyaluronic acid; MSC, mesenchymal stem cell; PAAm, polyacrylamide; PCL, poly(ε-caprolactone); PDMS, polydimethylsiloxane; PEG, poly(ethylene glycol); PES, poly(ether sulfone); PLGA, poly(lactic co-glycolic acid); PLLA, poly(L-lactic acid); RGD, arginine-glycine-aspartate; TG-Gtn, transglutaminase-gelatin.